Veru Inc is trading at $3.31 (+10.34%) as it rebounds from a sharp two-day selloff following its June 4 surge tied to the Novo Nordisk supply agreement.
- The current move appears to be a technical correction and valuation reset rather than a response to a new company announcement.
- Broader U.S. equities are firmer this morning, which may be providing additional support for speculative buying in the stock.